| Anti-TNF-α | Tumor necrosis factor-alpha inhibitors |
| aOR | Adjusted odds ratio |
| BCG | Bacillus Calmette-Guérin |
| CI | Confidence interval |
| DMARDs | Disease-modifying antirheumatic drugs |
| HBV | Hepatitis B virus |
| HCV | Hepatitis C virus |
| HIV | Human immunodeficiency virus |
| IGRAs | Interferon-gamma release assays |
| IMIDs | Immune-mediated inflammatory diseases |
| JAKi | Janus kinase inhibitors |
| LTBI | Latent tuberculosis infection |
| OR | Odds ratio |
| QFT-Plus | QuantiFERON-TB Gold Plus |
| TB | Tuberculosis |
| TNF-α | Tumor necrosis factor-alpha |
| TST | Tuberculin skin test |